Cite
Circulating miR‐130b‐ and miR‐21‐based diagnostic markers and therapeutic targets for hepatocellular carcinoma.
MLA
Zhang, Nannan, et al. “Circulating MiR‐130b‐ and MiR‐21‐based Diagnostic Markers and Therapeutic Targets for Hepatocellular Carcinoma.” Molecular Genetics & Genomic Medicine, vol. 7, no. 12, Dec. 2019, p. N.PAG. EBSCOhost, https://doi.org/10.1002/mgg3.1012.
APA
Zhang, N., Hu, Z., Qiang, Y., & Zhu, X. (2019). Circulating miR‐130b‐ and miR‐21‐based diagnostic markers and therapeutic targets for hepatocellular carcinoma. Molecular Genetics & Genomic Medicine, 7(12), N.PAG. https://doi.org/10.1002/mgg3.1012
Chicago
Zhang, Nannan, Zhenni Hu, Yong Qiang, and Xiaochao Zhu. 2019. “Circulating MiR‐130b‐ and MiR‐21‐based Diagnostic Markers and Therapeutic Targets for Hepatocellular Carcinoma.” Molecular Genetics & Genomic Medicine 7 (12): N.PAG. doi:10.1002/mgg3.1012.